Metabolic changes in prostate cancer patients with Androgen-ablation therapy (AAT) - UROCOR
Study identifier:NIS-OES-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Metabolic changes in prostate cancer patients with Androgen-ablation therapy (AAT)
Medical condition
Prostatic cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
Male
Actual Enrollment
197
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Mar 2011
Primary Completion Date: 01 Dec 2012
Study Completion Date: 01 Dec 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2012 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
